DrugInformations.org

Many gardeners will experience foot pain this season as a result of overlooking the needs of their feet. But a few minutes of preparation and good common sense can keep gardeners comfortable all season. “Gardening is an exertive weight-bearing activity and should be considered a sport rather than a passive hobby,” said Dr. Paul R. Kasdan, a board-certified podiatrist and medical director for OurHealthNetwork.

More: continued here

No Comments »

Serious injury in child pedestrians is more four times more common inthe poor areas of England than in affluent areas, according to researchreleased on April 1, 2008 in the BMJ Specialty journal Archivesof Disease in Childhood. To investigate this, researchers examined hospital admission rates inchildren aged 15 years or less between the years of 1999 and 2004.

More: continued here

No Comments »

CoreSpine Technologies, LLC, an emerging spinal device company announced the expansion of its platform technology for spinal implant procedures to include an application for minimally invasive fusion. The development of CoreSpine’s Technologies’ initial prototype concentrated on generating a complete and selective nucleus removal device. The technology was recently expanded to incorporate a cartilage removal device for endplate preparation.

More: continued here

No Comments »

DePuy Spine, Inc., a Johnson & Johnson company, announced the launch of the VERTIGRAFT® VG1® CERVICAL ALLOGRAFT, an innovative bio-implant for anterior cervical fusion surgery designed to align with the spinal anatomy for maximum stability and freeze-dried for easy storage. VG1 CERVICAL, co-developed by DePuy Spine and LifeNET Health®, is made of a single piece of high quality cortical bone that is freeze-dried for room temperature storage.

More: continued here

No Comments »

ArthroCare Corp. (Nasdaq: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced results from its five-year study evaluating the effectiveness of the TOPAZ MicroDebrider to treat common tendon disorders, and concluded patients who had the minimally invasive procedure were highly satisfied with the procedure and continue to experience pain relief.

More: continued here

No Comments »

Osteoporosis is often viewed as a women’s health issue, but one in 16 men over 65 suffers from the disease, and few men are currently tested or diagnosed. Because of the aging population, a dramatic increase in osteoporosis among men is expected in the near future. New recommendations from ACP call for physicians to screen for osteoporosis in older men, especially those over the age of 65.

More: continued here

No Comments »

Osteologix, Inc. (OLGX.OB), a specialty biopharmaceutical company, announced that the U. S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for its lead development candidate NB S101 (strontium malonate), for the treatment and prevention of osteoporosis. NB S101, a dual acting bone agent, has a demonstrated ability to decrease resorption of bone while maintaining formation of new bone.

More: continued here

No Comments »

Study Finds Little Difference in Osteoporosis Drugs for Preventing FracturesA study of pharmacy records of 43,135 people who began to take osteoporosis drugs between 2000 and 2005 found 1,051 nonvertebral fractures within 12 months and no large differences in fracture risk between those who took risedronate, raloxifene, and alendronate (Article, p. 637). Those who took nasal calcitonin had more nonvertebral fractures than those who took alendronate.

More: continued here

No Comments »

Reports published in The Lancet and the New England Journal of Medicine this week outline research that shows the impact that genetic variations could have on the risk of breaking a bone due to osteoporosis. Dani Preedy, Medical Policy Officer at the National Osteoporosis Society says, “These findings are really very exciting for the future. We welcome research which helps to increase understanding of the disease - particularly how genes are involved.

More: continued here

No Comments »

Pioneer Surgical Technology, Inc., a leader in innovative medical devices, announced the successful human implantation of its next generation cervical total disc replacement (TDR), NuNec Cervical Arthroplasty Device. The surgeries were performed by Drs. Hansen Yuan, Dewei Zou and Wenwen Wu in Beijing China, on patients with degenerative disc disease (DDD) otherwise indicated for standard fusion surgery. Dr.

More: continued here

No Comments »